Definition A very small (30 patients) clinical trial that evaluated the feasibility and safety of 17β-estradiol-eluting stent for treating single native vessel stenosis
Primary endpoints Death, MI-myocardial infarction, TLR–target lesion revascularisation, stent thrombosis at 1 month and 6 months
Conclusion 17-beta-estradiol–eluted stents appear feasible and safe, have low rates of binary restenosis and revascularisation.
The authors felt that the results warranted confirmation with a large, randomised multicentre trial.
Abbreviation for: ESTrogen and Stents to Eliminate Restenosis
Reference content.onlinejacc.org/cgi/content/abstract/43/6/1118 [/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]